|
2023
|
G/S
|
Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the res... |
|
2021
|
Invention
|
Jet milling method. Systems and methods are disclosed for simultaneously jet milling and conditio... |
|
|
Invention
|
Compositions for the treatment of a respiratory condition.
The present disclosure relates to the... |
|
|
Invention
|
Compositions for the treatment of a respiratory condition. The present disclosure relates to the ... |
|
2020
|
G/S
|
Chemical substances and products for use in the manufacture of medical preparations for treating ... |
|
|
G/S
|
Chemical additives for use in the manufacture of medical preparations Medical preparations for th... |
|
|
G/S
|
Chemical substances and products for use in the manufacture
of medical preparations. Medical pre... |
|
|
G/S
|
Chemical substances and products for use in the manufacture of medical preparations. Medical prep... |
|
2019
|
Invention
|
Formulation comprising glycopyrrolate, method and apparatus.
A method is disclosed for making a ... |
|
2018
|
Invention
|
Polymorphs. The invention relates to a polymorphic form of (S)-3-(3-(1-methyl-2-oxo-5-(pyrazolo[1... |
|
|
Invention
|
Use of stearate in an inhalable formulation. The present invention concerns a method for making a... |
|
|
Invention
|
Method for making a micronized dry powder formulation of glycopyrrolate and magnesium stearate. M... |
|
|
Invention
|
Method and formulation. Methods are disclosed for simultaneously jet milling and conditioning par... |
|
|
Invention
|
Manufacture of pharmaceutical compositions. The present invention relates to particles and to met... |
|
2017
|
Invention
|
Inhalable powder composition comprising il-13 antibody. An inhalable powder composition comprises... |
|
|
Invention
|
Method of making particles for use in a pharmaceutical composition. A method for making composite... |
|
|
Invention
|
Polymer. A PEGylated polymer is disclosed according to Formula 1 wherein n is any integer from 4 ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of diseases and conditions of the respiratory syste... |
|
|
Invention
|
Taurine compositions suitable for inhalation. The invention discloses spray-dried compositions fo... |
|
|
Invention
|
Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additive... |
|
|
Invention
|
Method of making particles for use in a pharmaceutical composition. The invention relates to a me... |
|
|
Invention
|
Pharmaceutical compositions for inhalation. The invention provides microparticles for use in a ph... |
|
|
Invention
|
Particles for use in a pharmaceutical composition. The invention provides a method of making a co... |
|
2016
|
G/S
|
Medical preparations; pharmaceutical preparations for
medical purposes; biological preparations ... |
|
|
Invention
|
Method of making particles for use in a pharmaceutical composition.
A method for making composit... |
|
|
Invention
|
Crystalline form of a jak3 kinase inhibitor. The invention relates to novel co-crystals of a drug... |
|
|
Invention
|
Polymorphs. The invention relates to a polymorphic forms of (S)-3-(3-(1-methyl-2-oxo-5-(pyrazolo[... |
|
|
Invention
|
Novel polymorphs. The invention relates to polymorphic forms of (S)-3-(3-(1-methyl-2-oxo-5-(pyraz... |
|
2015
|
Invention
|
Manufacture of pharmaceutical compositions.
The present invention relates to particles and to me... |
|
2014
|
Invention
|
Method and apparatus for making compositions for pulmonary administration.
A method is disclosed... |
|
|
Invention
|
Method and apparatus for making compositions for pulmonary administration. A method is disclosed ... |
|
|
Invention
|
Pharmaceutical formulations for dry powder inhalers. A powder for use in a dry powder inhaler com... |
|
|
Invention
|
Formulation comprising glycopyrrolate, method and apparatus. A method is disclosed for making a p... |
|
|
Invention
|
Taurine compositions suitable for inhalation.
The invention discloses spray-dried compositions f... |
|
2013
|
Invention
|
N-containing heteroaryl derivatives as jak3 kinase inhibitors. N-containing heteroaryl derivative... |
|
|
Invention
|
Method and apparatus.
A method is disclosed for making a pharmaceutical composition for pulmonar... |
|
|
Invention
|
Method and apparatus. A method is disclosed for making a pharmaceutical composition for pulmonary... |
|
|
Invention
|
Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for i... |
|
|
Invention
|
Suspension formulations.
The present invention relates to suspension formulations, especially th... |
|
|
Invention
|
Inhaler and formulation. A dry powder formulation suitable for delivery by inhalation comprising ... |
|
2012
|
Invention
|
Method of making composite particles for use in pharmaceutical compositions and composite particl... |
|
|
Invention
|
Devices and pharmaceutical compositions for enhancing dosing efficiency.
The present invention r... |
|
|
G/S
|
Inhalers for therapeutic use. Scientific research, development, design, analysis, testing and inv... |
|
2011
|
Invention
|
Compositions and uses.
According to the invention there is provided a method of treating and/or ... |
|
2010
|
G/S
|
Chemical substances and products for use in the manufacture of medical preparations. Pharmaceutic... |
|
2006
|
G/S
|
Chemicals for use in science and industry; chemical substances and products for use in the manufa... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; medicaments formulated for pulmonary delivery; medica... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; medicaments
formulated for pulmonary delivery; medic... |
|
2005
|
G/S
|
Scientific and technological services and research and design relating thereto; industrial analys... |
